Final analysis of the multinational, post-authorisation study (NISSO) to assess the long-term safety and effectiveness of sonidegib in patients (pts) with locally advanced basal cell carcinoma (laBCC)

Ítems similars

• Interim analysis of the multinational, post-authorization safety study (NISSO) to assess the long-term safety of sonidegib in patients with locally advanced basal cell carcinoma
  per: Ralf Gutzmer, et al.
  Publicat: (2024-11-01)
• Final analysis of the multinational, post-authorisation study (NISSO) to assess the long-term safety and effectiveness of sonidegib in patients (pts) with locally advanced basal cell carcinoma (laBCC)
  per: R. Gutzmer, et al.
  Publicat: (2026-01-01)
• Postauthorization Safety Study (NISSO) Assessing the Long-Term Safety Profile of Sonidegib in Patients With Locally Advanced Basal Cell Carcinoma: Interim Analysis From the Spanish Cohort
  per: S. Beà Ardébol, et al.
  Publicat: (2026-02-01)
• Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma
  per: Alessia Villani, et al.
  Publicat: (2020-04-01)
• Real-world effectiveness and safety of the Hedgehog inhibitor sonidegib in patients with locally advanced basal cell carcinoma from the multicenter skin cancer registry ADOREG
  per: M. Weichenthal, et al.
  Publicat: (2026-01-01)